BISTTRY11:57Live
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş.ONCSM
Main MarketChemicals, Petroleum, Rubber and Plastics
84.20−4.90 (−5.50%)
- Volume
- TRY 83.3M
- Day range
- 82.15 – 90.95
- Previous close
- 89.10
- Market cap
- TRY 2B
ONCSM Ratio Analysis: P/E, P/B, EV/EBITDA
35 key ratios for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş. (ONCSM) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.
Ratio Analysis
| P/E | 25.14 |
| P/B | 3.96 |
| EV/EBITDA | 7.25 |
| Dividend yield | — |
| Beta | — |
| Earnings per share | 3.3 TL |
| Book value per share | 21.2 TL |
| EBITDA | 159.8M TL |
| Net profit | 31M TL |
| Operating profit | 122.4M TL |
| Operating profit before finance costs | 122.4M TL |
| Net working capital | 286.8M TL |
| Gross margin | 54.30% |
| Operating margin | 25.63% |
| Net margin | 6.49% |
| Return on assets | 10.92% |
| Return on equity | 18.26% |
| Current ratio | 2.09 |
| Quick ratio | 1.58 |
| Cash ratio | — |
| Leverage ratio | 44.59 |
| Debt to equity | 0.80 |
| Debt to assets | 0.45 |
| Fixed assets to equity | 0.72 |
| Short-term debt share | 0.05 |
| Interest coverage | — |
| Receivables turnover | 1.01 |
| Days sales outstanding | 361 |
| Inventory turnover | 1.60 |
| Days inventory outstanding | 228 |
| Payables turnover | 2.25 |
| Days payables outstanding | 162 |
| Working capital turnover | 1.66 |
| Equity turnover | 0.95 |
| Asset turnover | 0.52 |
Frequently asked questions
What is the P/E ratio of ONCSM?
ONCSM has a P/E ratio of 25.14, a P/B ratio of 3.96 and an EV/EBITDA of 7.25.
When are the ratios updated?
Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.